Orla Hardiman BSc, MB, BCh, BAO, MD, FRCPI, FTCD, MRIA
Clinical Professor Neurology Trinity College Dublin
Consultant Neurologist at the National Neuroscience Centre
Director of the National ALS Clinic & Irish ALS Research Group
Key Areas: Neurodegeneration, Deep Phenotyping, Epidemiology, Complex Genomics, Biomarkers, Clinical Trials
Orla Hardiman is a science and medical graduate from University College Dublin , and is a prominent Irish Clinician Scientist who holds the Chair of Neurology at Trinity College Dublin.
She leads a team of 35 researchers focusing on neurodegeneration, with specific emphasis on Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Her work is focused on epidemiology, clinical phenotyping, genomics, biomarker development, and clinical trial design in rare neurodegenerations. She has developed extensive collaborations with clinicians in the Caribbean, South America and North Africa, with the purpose of enhancing care and promoting research into age related non-Alzheimer neurodegeneration in developing countries.
Bio: Professor Hardiman trained in Neurology in Boston prior to her appointment as a Consultant Neurologist at Beaumont Hospital Dublin. In 2011, she established the Academic Unit of Neurology at Trinity College Dublin and was appointed the first Professor of Neurology in the country in 2013. In 2015 she was elected as a Fellow of Trinity College Dublin, and was of the first three active clinicians ever to be elected as a Member of the Royal Irish Academy in 2015. She is the recipient of many international honours and awards, and a recognized world leader in ALS and FTD research. Her research interests are in clinical and translational neuroscience and she is world leader in the epidemiology, phenotype, genomics and neural networking of Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, and related conditions. She has published over 350 peer reviewed publications, and her work is funded by the Health Research Board, Science Foundation Ireland, and the charities ALSA and MNDA, IMNDA and RMN.